GlassScriptPhysician profile
Timothy A Lucas
NPI 1598723629
$24,786.21
in general payments reported to CMS, 2019-2025
54 companies · $3,686 in 2025
The $3,686 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,062 · 2020: $6,330 · 2021: $3,110 · 2022: $2,736 · 2023: $2,634 · 2024: $3,230 · 2025: $3,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,183 · Education: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,183.07 |
| Education | $365.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $6,578.32 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $4,420.84 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,333.76 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Genzyme Corporation | $1,085.67 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $1,081.92 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Jazz Pharmaceuticals INC. | $1,005.66 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $863.01 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $627.86 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $558.68 | 2019-2024 | Yupelri |
| Insmed, INC. | $523.27 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $502.27 | 2019-2024 | Tyvaso, Orenitram |
| Harmony Biosciences LLC | $436.79 | 2020-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $394.38 | 2020-2025 | Glassia |
| Genentech USA, INC. | $384.81 | 2019-2025 | Xolair |
| Pfizer INC. | $365.82 | 2019-2021 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $340.88 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $333.38 | 2020-2024 | Acthar |
| Philips North America LLC | $332.85 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Electromed, INC. | $303.32 | 2019-2025 | Smartvest |
| Resmed Corp | $303.25 | 2019-2025 | |
| Axsome Therapeutics, INC. | $278.62 | 2023-2025 | Sunosi |
| Sanofi-Aventis U.S. LLC | $266.93 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $210.14 | 2019-2025 | Winrevair, Belsomra, Keytruda |
| Inspire Medical Systems, INC. | $194.43 | 2023-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $187.08 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $167.49 | 2024-2025 | Lumryz |
| Amgen INC. | $164.77 | 2022-2025 | Tezspire |
| Advanced Respiratory, INC | $136.65 | 2019-2021 | |
| Eisai INC. | $119.40 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $100.18 | 2020-2022 | |
| Baxter Healthcare | $98.72 | 2022-2023 | Hillrom - Monarch Airway Clearance System |
| Vifor Pharma, INC. | $98.01 | 2024-2025 | Zemaira |
| Verona Pharma, INC. | $87.66 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $84.22 | 2019-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Zoll Respicardia, INC. | $81.41 | 2022 | |
| Shire North American Group INC | $80.90 | 2019 | |
| Paratek Pharmaceuticals, INC. | $70.00 | 2023-2025 | Nuzyra |
| Allergan, INC. | $54.54 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $54.50 | 2024-2025 | Purified Cortrophin Gel |
| Circassia INC. | $54.29 | 2019-2020 | |
| Abbvie INC. | $54.10 | 2021-2024 | |
| 3b Medical, INC. | $49.71 | 2025 | Luna |
| Idorsia Pharmaceuticals US INC | $48.36 | 2023 | Quviviq |
| Sunovion Pharmaceuticals INC. | $37.30 | 2019 | |
| Vapotherm INC | $35.78 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.52 | 2020 | |
| Viatris Specialty LLC | $32.90 | 2025 | Yupelri |
| Optinose US, INC. | $29.70 | 2021 | |
| Seqirus USA INC | $19.48 | 2025 | Fluad, Flucelvax |
| Tactile Systems Technology INC | $18.42 | 2025 | Flexitouch Plus, Nimbl |
| Melinta Therapeutics, LLC | $16.92 | 2019 | |
| Lilly USA, LLC | $14.97 | 2025 | Zepbound |
| Alexion Pharmaceuticals, INC. | $14.79 | 2020 | |
| Ucb, INC. | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.